Looks to me like the management are aware of what they need to do. No reason to think they're not. Larger investors are apparently comfortable with same, given volumes.
Theres clearly something of great value here. Post daughters illness I can't stop thinking about the value of a broad spectrum, non resistant option even for triage or general prevention. Timely minimisation of these viral conditions alone is of great significance.
Hopefully more detail of talks and progress comes to light in the quarterly. I think once we have a path to demonstration for FDA and these 3 (maybe more now) BPs I think we'll start to see this SP move up accordingly, if not as MM said we could get a deal without notice... which would be satisfying also quite amusing.
DYOR
GLTA
BIT Price at posting:
3.3¢ Sentiment: Buy Disclosure: Held
